Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/4486
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKumar, Nirmal-
dc.contributor.authorPrabhu, Suchitra S.-
dc.contributor.authorMonga, Isha-
dc.contributor.authorBanerjee, Indranil-
dc.date.accessioned2023-08-10T17:59:09Z-
dc.date.available2023-08-10T17:59:09Z-
dc.date.issued2021-
dc.identifier.citationMeta Gene, 29en_US
dc.identifier.urihttp://10.0.3.248/j.mgene.2021.100909-
dc.identifier.urihttp://hdl.handle.net/123456789/4486-
dc.descriptionOnly IISER Mohali authors are available in the record.en_US
dc.description.abstractPrevious studies suggested, variations in the IL28B gene can serve as predictors of sustained and rapid virological responses (SVR and RVR) in the treatment of HCV with pegylated interferon and ribavirin (pegINF-RBV) among HCV-HIV co-infected patients. Here, we explored the correlation between IL28B variants (rs12979860, rs8099917 and rs12980275) and treatment response for HCV among co-infected individuals using meta-analysis.en_US
dc.language.isoen_USen_US
dc.publisherMeta Geneen_US
dc.subjectIL28Ben_US
dc.subjectHIV-HCV co-infectionen_US
dc.subjectPegylated interferon and ribavirinen_US
dc.subjectSNPen_US
dc.subjectMeta-analysisen_US
dc.titleInfluence of IL28B gene polymorphisms on PegINF-RBV-mediated HCV clearance in HIV-HCV co-infected patients: A meta-analysis Author links open overlay panelen_US
dc.typeArticleen_US
Appears in Collections:Research Articles

Files in This Item:
File Description SizeFormat 
Need To Add…Full Text_PDF..pdfOnly IISER Mohali authors are available in the record.15.36 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.